Zhongyuan Bio

Zhongyuan Huiji Biotechnology Joint-stock Co., Ltd. is a high-tech enterprise specializing in the research, development, production, sales, and technical services of in vitro diagnostic reagents and instruments. The company's headquarters building and manufacturing center are located in Dadukou District, Chongqing. Zhongyuan Huiji has over 3,800 employees globally, with R&D personnel accounting for more than 30%, and nearly 50% of R&D personnel holding master's degrees or above. As a postdoctoral research workstation, Zhongyuan Huiji continuously supports the transformation of scientific research achievements, and has established eight R&D centers in Chongqing, Beijing, Shanghai, Guangzhou, Shenzhen, Nanjing, Xiamen, and Changchun. Zhongyuan Huiji deeply focuses on cutting-edge technologies in in vitro diagnostics, regarding R&D as the core driving force for sustainable development. The company's main business covers diagnostic products such as biochemistry, immunology, molecular, POCT, clinical laboratory, microbiology, pathology, as well as upstream raw materials. The company has also made comprehensive arrangements in core technical fields such as biological raw materials and chemical raw materials, possessing core technologies including genetic engineering antigens/antibodies, diagnostic nanomaterials, high-precision diagnostic instrument and core component development, multiple labeling signal amplification, and rapid nucleic acid extraction and detection. The company has obtained nearly 60 invention patents and 623 product registration certificates. In 2018, Zhongyuan Huiji officially established a standardized reference measurement laboratory, and some projects have passed the high-level quality evaluation in the field of global clinical chemistry—the International Reference Laboratory Proficiency Testing (IFCC-RELA). Zhongyuan Huiji currently has production plants covering more than 100,000 square meters, equipped with qualified modern production workshops, and has 19 production lines for reagents and instruments. The production process strictly follows national unified standards and has passed ISO9001 and ISO13485 certifications. Currently, the annual production capacity can reach 3 billion person-times of reagents and 35,000 instruments. Zhongyuan Huiji has become a leading enterprise in the medical device field in Chongqing and one of the top 100 manufacturing enterprises in Chongqing, with 79 service teams established in 31 provinces, municipalities, and autonomous regions across China. The company has established offices in multiple overseas countries, and its products have covered more than 100 countries worldwide, spanning five continents: Asia, South America, North America, Europe, and Africa. The company has built a comprehensive marketing and service system, with the capability of "1-hour response, 12-hour arrival". Its products and solutions are applied in more than 13,000 hospitals globally. "True feelings in every drop, only for precision," Zhongyuan Huiji will continue to meet customers' diverse needs, deeply cultivate the in vitro diagnostics industry with dedication, innovation, and expansion, deepen cooperation with global medical institutions, create greater value for customers, and strive to become an internationally renowned IVD brand.